Suppr超能文献

跨国别和跨环境的成本效用分析的可推广性。

Generalizability of cost-utility analyses across countries and settings.

机构信息

Medical Technology Assessment Sector, Ministry of Health, Yirmiahu St 39, Jerusalem 944724, Israel.

出版信息

Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):845-52. doi: 10.1016/j.bpg.2013.08.017. Epub 2013 Sep 26.

Abstract

All societies have limited resources, so decisions have to be made about which public health interventions should be provided. A major tool used for prioritisation is cost-utility analysis (CUA) where the outcomes are measured in terms of Disability Adjusted Life Years (DALYs) prevented. Collecting data and building models to calculate the ratio of net costs (i.e.: intervention costs less treatment costs averted due to decreases in morbidity and mortality) to outcomes (CUR) is complex and time consuming. Therefore, there is a great appeal in using CUA calculations that have already been published in other countries. This paper points out the many limitations and inaccuracies caused by generalizing results from CUAs across different countries. However, if time constraints are pressing then first-order estimates of results could be presented after adjustments for the major drivers of the CUR, such as incidence rates, intervention costs and averted treatment costs.

摘要

所有社会的资源都是有限的,因此必须对应当提供哪些公共卫生干预措施做出决策。用于优先排序的主要工具是成本效益分析(CUA),其中结果以预防的残疾调整生命年(DALYs)来衡量。收集数据和建立模型来计算净成本(即:由于发病率和死亡率降低而避免的干预成本减去治疗成本)与结果(CUR)的比率非常复杂且耗时。因此,使用已经在其他国家发表的 CUA 计算结果具有很大的吸引力。本文指出了将来自不同国家的 CUA 结果推广时会产生的许多局限性和不准确性。但是,如果时间紧迫,则可以在调整 CUR 的主要驱动因素(如发病率、干预成本和避免的治疗成本)之后,提供结果的一阶估计。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验